β-Catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial–myofibroblast transition
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Injury to the adherens junctions (AJs) synergizes with transforming growth factor-β1 (TGFβ) to activate a myogenic program (α-smooth muscle actin [SMA] expression) in the epithelium during epithelial–myofibroblast transition (EMyT). Although this synergy plays a key role in organ fibrosis, the underlying mechanisms have not been fully defined. Because we recently showed that Smad3 inhibits myocardin-related transcription factor (MRTF), the driver of the SMA promoter and many other CC(A/T)-rich GG element (CArG) box–dependent cytoskeletal genes, we asked whether AJ components might affect SMA expression through interfering with Smad3. We demonstrate that E-cadherin down-regulation potentiates, whereas β-catenin knockdown inhibits, SMA expression. Contact injury and TGFβ enhance the binding of β-catenin to Smad3, and this interaction facilitates MRTF signaling by two novel mechanisms. First, it inhibits the Smad3/MRTF association and thereby allows the binding of MRTF to its myogenic partner, serum response factor (SRF). Accordingly, β-catenin down-regulation disrupts the SRF/MRTF complex. Second, β-catenin maintains the stability of MRTF by suppressing the Smad3-mediated recruitment of glycogen synthase kinase-3β to MRTF, an event that otherwise leads to MRTF ubiquitination and degradation and the consequent loss of SRF/MRTF–dependent proteins. Thus β-catenin controls MRTF-dependent transcription and emerges as a critical regulator of an array of cytoskeletal genes, the “CArGome.”
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both MKL-1 and YAP/TAZ directly regulate myofibroblast phenotype.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has been reported that TGF‐β regulates the stability of TAZ and MRTFs [41, 42].”
From Mechanical stiffness orchestrates distinct regulation of MRTFs and YAP / TAZ transcriptional cofactors in hepatocytes (2026) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Kapoor, M., Liu, S., Shi-wen, X., Huh, K., McCann, M., Denton, C. P., Woodgett, J. R., Abraham, D. J., & Leask, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35381 · Cited by 66 · cited 2×
“Consistent with our proposal that GSK-3β is a key determinant of MRTF stability, deletion of GSK-3β facilitates SMA expression in fibroblasts (Kapoor et al., 2008); GSK-3β has been shown to phosphorylate myocardin, thereby reducing its transcriptional activity (Badorff et al.”
BackgroundRetractedKapoor, M., Liu, S., Shiwen, X., Huh, K., McCann, M. R., Denton, C. P., Woodgett, J. R., Abraham, D., & Leask, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35381r1 · Cited by 51
RetractedThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 1×
“During fibrogenic (type 2) EMT, epithelial cells lose their strong intercellular contacts and apicobasal polarity and acquire fibroblast-like features, such as elongated shape, increased extracellular matrix (ECM) production, and motility (Zeisberg and Neilson, 2009).”
BackgroundGSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · cited 1×
“Beside the possibility of increased β-catenin availability, C-terminal or linker-region phosphorylation of Smad3 (Kamaraju and Roberts, 2005) and/or serine dephosphorylation or tyrosine phosphorylation of β-catenin (Doble and Woodgett, 2003) might also contribute.”
BackgroundLoss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,522 · cited 4×
“These observations are congruent with data obtained during tumor EMT, showing that elimination of E-cadherin stabilizes free β-catenin and increases the SMA message (Onder et al., 2008).”
BackgroundResultInfluentialEpithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M., & Nieto, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38019 · Cited by 1,370 · cited 2×
“INTRODUCTION Epithelial–mesenchymal transition (EMT), a process characterized by cytoskeletal remodeling and transcriptional reprogramming, has long been known to play a key role in development and carcinogenesis (Acloque et al., 2009).”
BackgroundActin dynamics control SRF activity by regulation of its coactivator MAL
Miralles, F., Posern, G., Zaromytidou, A.-I., & Treisman, R. (2003) · Cell · doi:10.1016/s0092-8674(03)00278-2 · Cited by 1,327 · cited 1×
“On Factin polymerization (induced by various stimuli and mediated predominantly by Rho family GTPases), G-actin dissociates from MRTF, which results in nuclear translocation of MRTF (Miralles et al., 2003; Vartiainen et al., 2007).”
BackgroundLinking actin dynamics and gene transcription to drive cellular motile functions
Olson, E. N., & Nordheim, A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2890 · Cited by 958 · cited 1×
“The first mechanism involves myocardin-related transcription factor (MRTF), a recently discovered activator of serum response factor (SRF) that links cytoskeleton remodeling and the transcriptional control of cytoskeletal components (Wang et al., 2002; Olson and Nordheim, 2010).”
BackgroundNew Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Liu, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121226 · Cited by 870 · cited 2×
“Volume 22 December 1, 2011 β-catenin in EMyT | 4473 protein-1 or SMA (Wendt et al., 2009; Liu, 2010).”
Nuclear Actin Regulates Dynamic Subcellular Localization and Activity of the SRF Cofactor MAL
Vartiainen, M. K., Guettler, S., Larijani, B., & Treisman, R. (2007) · Science · doi:10.1126/science.1141084 · Cited by 622 · cited 3×
“On Factin polymerization (induced by various stimuli and mediated predominantly by Rho family GTPases), G-actin dissociates from MRTF, which results in nuclear translocation of MRTF (Miralles et al., 2003; Vartiainen et al., 2007).”
BackgroundWang, D.-Z., Li, S., Hockemeyer, D., Sutherland, L., Wang, Z., Schratt, G., Richardson, J. A., Nordheim, A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222561499 · Cited by 474 · cited 1×
“The first mechanism involves myocardin-related transcription factor (MRTF), a recently discovered activator of serum response factor (SRF) that links cytoskeleton remodeling and the transcriptional control of cytoskeletal components (Wang et al., 2002; Olson and Nordheim, 2010).”
BackgroundNg, Y.-Y., Huang, T.-P., Yang, W.-C., Chen, Z.-P., Yang, A.-H., Mu, W., Nikolic-Paterson, D. J., Atkins, R. C., & Lan, H. Y. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00076.x · Cited by 398 · cited 1×
“Moreover, EMT can progress further toward the activation of a myogenic program, resulting in the transdifferentiation of epithelial cells to myofibroblasts (MFs), marked by the expression of α-smooth muscle actin (SMA) (Ng et al., 1998; Masszi et al., 2003).”
BackgroundKim, K. K., Wei, Y., Szekeres, C., Kugler, M. C., Wolters, P. J., Hill, M. L., Frank, J. A., Brumwell, A. N., Wheeler, S. E., Kreidberg, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36940 · Cited by 397
Liebner, S., Cattelino, A., Gallini, R., Rudini, N., Iurlaro, M., Piccolo, S., & Dejana, E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403050 · Cited by 376 · cited 20×
“Transforming growth factor-β1 (TGFβ) is the chief inducer of EMT/EMyT, which contributes to all aspects of the process, including the down-regulation of epithelial cell contact molecules (e.g., the adherens junction [AJ] constituent E-cadherin), the up-regulation of ECM components (e.g., collagen, fibronectin), and th…”
BackgroundInfluentialROBERTS, A., TIAN, F., BYFIELD, S., STUELTEN, C., OOSHIMA, A., SAIKA, S., & FLANDERS, K. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.008 · Cited by 348 · cited 17×
“Transforming growth factor-β1 (TGFβ) is the chief inducer of EMT/EMyT, which contributes to all aspects of the process, including the down-regulation of epithelial cell contact molecules (e.g., the adherens junction [AJ] constituent E-cadherin), the up-regulation of ECM components (e.g., collagen, fibronectin), and th…”
BackgroundInfluentialSmad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
Meng, X. M., Huang, X. R., Chung, A. C. K., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121244 · Cited by 338 · cited 2×
“…of EMT, fibrosis, and MF accumulation is often accompanied by a reduction in Smad3 (or Smad2) levels (Zhao and Geverd, 2002; Poncelet et al., 2007; Meng et al., 2010), and suppression of Smad3 can actually facilitate SMA expression (Masszi et al., 2010); for a review see Masszi and Kapus (2011).”
BackgroundSmad3 Mediates Transforming Growth Factor-β–Induced α-Smooth Muscle Actin Expression
Hu, B., Wu, Z., & Phan, S. H. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0063oc · Cited by 325 · cited 2×
“…the rat SMA promoter in a pGL3-basic vector (WT), the constructs harboring an inactivating mutation at the SBE1 or SBE2 sites (SBE1mut and SBE2mut) (Hu et al., 2003), and the p152-SMA-Luc reporter (provided by S. H. Phan, University of Michigan Medical School, Ann Arbor, MI) were described in our…”
Kolligs, F. T., Hu, G., Dang, C. V., & Fearon, E. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5696 · Cited by 319 · cited 2×
“Fearon (University of Michigan, Ann Arbor, MI) (Kolligs et al., 1999).”
MethodMechanisms of the Epithelial–Mesenchymal Transition by TGF-β
Wendt, M. K., Allington, T. M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/fon.09.90 · Cited by 317 · cited 2×
“Volume 22 December 1, 2011 β-catenin in EMyT | 4473 protein-1 or SMA (Wendt et al., 2009; Liu, 2010).”
Cheon, S. S., Cheah, A. Y. L., Turley, S., Nadesan, P., Poon, R., Clevers, H., & Alman, B. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102657399 · Cited by 313
Fuxe, J., Vincent, T., & Garcia de Herreros, A. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12050 · Cited by 311 · cited 1×
“In addition to targeting their own sites, they form active transcriptional complexes (Lei et al., 2004; Clifford et al., 2008; Fuxe et al., 2010).”
BackgroundDefining the mammalian CArGome
Sun, Q., Chen, G., Streb, J. W., Long, X., Yang, Y., Stoeckert, C. J., & Miano, J. M. (2006) · Genome Research · doi:10.1101/gr.4108706 · Cited by 289 · cited 6×
“, 2006), and the complex drives gene transcription through the CC(A/T)6GG cis elements (CArG boxes) present in the promoters of a large array of muscle-type and cytoskeletal genes (the “CArGome”) (Du et al., 2004; Tomasek et al., 2005; Sun et al., 2006), including SMA.”
BackgroundInfluentialMorita, T., Mayanagi, T., & Sobue, K. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200708174 · Cited by 262 · cited 8×
“E-Cadherin down-regulation facilitates TGFβ-induced SMA expression Our previous studies showed that disruption or absence of intercellular contacts (as induced by LCM, scratch wounding, or subconfluence) enables TGFβ to provoke SMA expression in tubular epithelial (LLC-PK1) cells (Masszi et al., 2004; Fan et al., 2007…”
BackgroundInfluentialSurendran, K., Schiavi, S., & Hruska, K. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110949 · Cited by 259 · cited 1×
“β-Catenin levels show characteristic changes in fibroblasts during wound healing or fibrosis (Cheon et al., 2002, 2005; Surendran et al., 2005), with a postinjury rise followed by a gradual decrease if tissue restoration occurs.”
BackgroundTamiya, S., Liu, L., & Kaplan, H. J. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4725 · Cited by 247 · cited 1×
“…contacts has emerged as an important contributor to EMT/EMyT (Masszi et al., 2004; Fan et al., 2007; Kim et al., 2009b; Zheng et al., 2009; Tamiya et al., 2010), and the AJ component β-catenin has been shown to promote the myogenic program in the epithelium (Masszi et al., 2004) and other…”
BackgroundMasszi, A., Fan, L., Rosivall, L., McCulloch, C. A., Rotstein, O. D., Mucsi, I., & Kapus, A. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63247-6 · Cited by 244 · cited 18×
“Transforming growth factor-β1 (TGFβ) is the chief inducer of EMT/EMyT, which contributes to all aspects of the process, including the down-regulation of epithelial cell contact molecules (e.g., the adherens junction [AJ] constituent E-cadherin), the up-regulation of ECM components (e.g., collagen, fibronectin), and th…”
BackgroundMethodResultInfluentialSelf-citationMasszi, A., Di Ciano, C., Sirokmány, G., Arthur, W. T., Rotstein, O. D., Wang, J., McCulloch, C. A. G., Rosivall, L., Mucsi, I., & Kapus, A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00183.2002 · Cited by 242 · cited 2×
“Moreover, EMT can progress further toward the activation of a myogenic program, resulting in the transdifferentiation of epithelial cells to myofibroblasts (MFs), marked by the expression of α-smooth muscle actin (SMA) (Ng et al., 1998; Masszi et al., 2003).”
BackgroundMethodInfluentialSelf-citationZheng, G., Lyons, J. G., Tan, T. K., Wang, Y., Hsu, T.-T., Min, D., Succar, L., Rangan, G. K., Hu, M., Henderson, B. R., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080983 · Cited by 230 · cited 2×
“Injury to the intercellular contacts has emerged as an important contributor to EMT/EMyT (Masszi et al., 2004; Fan et al., 2007; Kim et al., 2009b; Zheng et al., 2009; Tamiya et al., 2010), and the AJ component β-catenin has been shown to promote the myogenic program in the epithelium (Masszi et…”
BackgroundKamaraju, A. K., & Roberts, A. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m403960200 · Cited by 227
Fan, L., Sebe, A., Péterfi, Z., Masszi, A., Thirone, A. C. P., Rotstein, O. D., Nakano, H., McCulloch, C. A., Szászi, K., Mucsi, I., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0602 · Cited by 173
Self-citationA role for Wnt-4 in renal fibrosis
Surendran, K., McCaul, S. P., & Simon, T. C. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0009.2001 · Cited by 164 · cited 2×
“, 2005), organ fibrosis (Surendran et al., 2002; Kim et al., 2009a), tissue specification (Liebner et al.”
BackgroundIntegrin α3β1–dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts
Kim, Y., Kugler, M. C., Wei, Y., Kim, K. K., Li, X., Brumwell, A. N., & Chapman, H. A. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200806067 · Cited by 160
Du, K. L., Chen, M., Li, J., Lepore, J. J., Mericko, P., & Parmacek, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400961200 · Cited by 150 · cited 6×
“, 2006), and the complex drives gene transcription through the CC(A/T)6GG cis elements (CArG boxes) present in the promoters of a large array of muscle-type and cytoskeletal genes (the “CArGome”) (Du et al., 2004; Tomasek et al., 2005; Sun et al., 2006), including SMA.”
BackgroundInfluentialRho/Rho-associated Kinase-II Signaling Mediates Disassembly of Epithelial Apical Junctions
Samarin, S. N., Ivanov, A. I., Flatau, G., Parkos, C. A., & Nusrat, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0315 · Cited by 138 · cited 1×
“We and others showed that acute disruption of AJs stimulates Rho (Fan et al., 2007; Samarin et al., 2007) and redistributes MRTF to the nucleus (Fan et al., 2007; Busche et al., 2008).”
BackgroundFate-determining mechanisms in epithelial–myofibroblast transition: major inhibitory role for Smad3
Masszi, A., Speight, P., Charbonney, E., Lodyga, M., Nakano, H., Szászi, K., & Kapus, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200906155 · Cited by 129 · cited 25×
“We showed previously (Masszi et al., 2010) that MRTF is required for the basal and/or stimulus-induced expression of several CArG-regulated proteins, including filamin, CapZ, cofilin, and SRF itself.”
BackgroundMethodResultInfluentialSelf-citationβ-Catenin Signaling in Fibroproliferative Disease
Bowley, E., O’Gorman, D. B., & Gan, B. S. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.07.026 · Cited by 120 · cited 2×
“, 2004), fibrogenesis (Bowley et al., 2007; Kim et al., 2009a), smooth muscle differentiation, and SMA expression (Gosens et al.”
BackgroundJohansen, F. E., & Prywes, R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4640 · Cited by 119
Tian, Y., & Phillips, A. O. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61109-1 · Cited by 112 · cited 1×
“On the other hand, β-catenin has been described as a binding partner of Smad3 (Tian and Phillips, 2002; Zhang et al., 2007, 2010).”
BackgroundSmad3 Prevents β-Catenin Degradation and Facilitates β-Catenin Nuclear Translocation in Chondrocytes
Zhang, M., Wang, M., Tan, X., Li, T.-F., Zhang, Y. E., & Chen, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093526 · Cited by 105 · cited 4×
“It was recently reported (Zhang et al., 2010) that the N-terminal and armadillo domain of β-catenin associates with the C-terminal region of Smad3.”
BackgroundInfluentialMuehlich, S., Wang, R., Lee, S.-M., Lewis, T. C., Dai, C., & Prywes, R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00427-08 · Cited by 104 · cited 1×
“Thus G-actin affinity of intranuclear MRTF is regulated by MAP kinase–dependent phosphorylation (Muehlich et al., 2008), whereas the present studies demonstrate that the MRTF–Smad3 interaction depends on the availability of β-catenin.”
BackgroundTomasek, J. J., McRae, J., Owens, G. K., & Haaksma, C. J. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62353-x · Cited by 101 · cited 1×
“…with SRF (Zaromytidou et al., 2006), and the complex drives gene transcription through the CC(A/T)6GG cis elements (CArG boxes) present in the promoters of a large array of muscle-type and cytoskeletal genes (the “CArGome”) (Du et al., 2004; Tomasek et al., 2005; Sun et al., 2006), including SMA.”
BackgroundZaromytidou, A.-I., Miralles, F., & Treisman, R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01902-05 · Cited by 101 · cited 2×
“Once there, MRTF associates with SRF (Zaromytidou et al., 2006), and the complex drives gene transcription through the CC(A/T)6GG cis elements (CArG boxes) present in the promoters of a large array of muscle-type and cytoskeletal genes (the “CArGome”) (Du et al.”
BackgroundTomasek, J. J., Vaughan, M. B., Kropp, B. P., Gabbiani, G., Martin, M. D., Haaksma, C. J., & Hinz, B. (2006) · Wound Repair and Regeneration · doi:10.1111/j.1743-6109.2006.00126.x · Cited by 98 · cited 1×
“This could contribute to normal healing by facilitating wound closure (contractility; Tomasek et al., 2006) and reepithelialization.”
BackgroundTGFβ and Wnt pathway cross-talk
Attisano, L., & Labbé, E. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025811012690 · Cited by 98 · cited 1×
“Because extensive cross-talk exists between the β-catenin/TCF-LEF and TGFβ/ Smad3 pathways (Attisano and Labbe, 2004) and β-catenin can bind to Smad3, an interaction with Smad3 was a plausible possibility.”
BackgroundLei, S., Dubeykovskiy, A., Chakladar, A., Wojtukiewicz, L., & Wang, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404025200 · Cited by 97 · cited 1×
“In addition to targeting their own sites, they form active transcriptional complexes (Lei et al., 2004; Clifford et al., 2008; Fuxe et al., 2010).”
BackgroundNovel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor β1
Clifford, R. L., Deacon, K., & Knox, A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803342200 · Cited by 95 · cited 1×
“In addition to targeting their own sites, they form active transcriptional complexes (Lei et al., 2004; Clifford et al., 2008; Fuxe et al., 2010).”
BackgroundCheon, S. S., Poon, R. W. M., Yu, C., Khoury, M., Shenker, R., Fish, J. S., & Alman, B. A. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700237 · Cited by 93 · cited 2×
“…component β-catenin has been shown to promote the myogenic program in the epithelium (Masszi et al., 2004) and other cell types during wound healing (Cheon et al., 2005), organ fibrosis (Surendran et al., 2002; Kim et al., 2009a), tissue specification (Liebner et al., 2004), carcinogenesis (Onder…”
BackgroundEpithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling
Busche, S., Descot, A., Julien, S., Genth, H., & Posern, G. (2008) · Journal of Cell Science · doi:10.1242/jcs.014456 · Cited by 89 · cited 5×
“Our observations can also explain the need for the double hit for SMA expression: contact disassembly induces nuclear translocation of MRTF (Fan et al., 2007; Busche et al., 2008; Sebe et al., 2008) and elevates the level of cytosolic β-catenin (present study; Masszi et al.”
BackgroundInfluentialSasazuki, T., Sawada, T., Sakon, S., Kitamura, T., Kishi, T., Okazaki, T., Katano, M., Tanaka, M., Watanabe, M., Yagita, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203190200 · Cited by 86
Self-citationBadorff, C., Seeger, F. H., Zeiher, A. M., & Dimmeler, S. (2005) · Circulation Research · doi:10.1161/01.res.0000184684.88750.fe · Cited by 79
Xie, P., Fan, Y., Zhang, H., Zhang, Y., She, M., Gu, D., Patterson, C., & Li, H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01737-08 · Cited by 76 · cited 4×
“…SMA expression in fibroblasts (Kapoor et al., 2008); GSK-3β has been shown to phosphorylate myocardin, thereby reducing its transcriptional activity (Badorff et al., 2005); and the E3 ligase CHIP was reported to promote myocardin ubiquitination in a GSK-3β– dependent manner (Xie et al., 2009).”
BackgroundInfluentialMKL1 mediates TGF-β1-induced α-smooth muscle actin expression in human renal epithelial cells
Elberg, G., Chen, L., Elberg, D., Chan, M. D., Logan, C. J., & Turman, M. A. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00142.2007 · Cited by 75 · cited 6×
“Indeed, knockdown studies revealed that MRTF is indispensable for the TGFβ-induced (Morita et al., 2007; Elberg et al., 2008) and contact injury–facilitated EMyT (Fan et al.”
BackgroundInfluentialCho, I. J., Kim, Y. W., Han, C. Y., Kim, E. H., Anderson, R. A., Lee, Y. S., Lee, C. H., Hwang, S. J., & Kim, S. G. (2010) · Hepatology · doi:10.1002/hep.23931 · Cited by 72 · cited 2×
“This could be due to the fact that E-cadherin counteracts TGFβ-induced Rho activation (Cho et al., 2010).”
BackgroundInhibition of Glycogen Synthase Kinase-3β Is Sufficient for Airway Smooth Muscle Hypertrophy
Deng, H., Dokshin, G. A., Lei, J., Goldsmith, A. M., Bitar, K. N., Fingar, D. C., Hershenson, M. B., & Bentley, J. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800624200 · Cited by 68 · cited 2×
“, 2008), and hypertrophy (Deng et al., 2008; Gosens et al., 2008).”
BackgroundSmaddening Complexity: The Role of Smad3 in Epithelial-Myofibroblast Transition
Masszi, A., & Kapus, A. (2011) · Cells Tissues Organs · doi:10.1159/000320180 · Cited by 64 · cited 1×
“…of EMT, fibrosis, and MF accumulation is often accompanied by a reduction in Smad3 (or Smad2) levels (Zhao and Geverd, 2002; Poncelet et al., 2007; Meng et al., 2010), and suppression of Smad3 can actually facilitate SMA expression (Masszi et al., 2010); for a review see Masszi and Kapus (2011).”
BackgroundSelf-citationPoncelet, A.-C., Schnaper, H. W., Tan, R., Liu, Y., & Runyan, C. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701991200 · Cited by 51 · cited 1×
“…since the progression of EMT, fibrosis, and MF accumulation is often accompanied by a reduction in Smad3 (or Smad2) levels (Zhao and Geverd, 2002; Poncelet et al., 2007; Meng et al., 2010), and suppression of Smad3 can actually facilitate SMA expression (Masszi et al., 2010); for a review see…”
BackgroundSebe, A., Masszi, A., Zulys, M., Yeung, T., Speight, P., Rotstein, O. D., Nakano, H., Mucsi, I., Szászi, K., & Kapus, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.12.021 · Cited by 51 · cited 3×
“…the need for the double hit for SMA expression: contact disassembly induces nuclear translocation of MRTF (Fan et al., 2007; Busche et al., 2008; Sebe et al., 2008) and elevates the level of cytosolic β-catenin (present study; Masszi et al., 2004), whereas TGFβ is required to rescue β-catenin…”
BackgroundSelf-citationZhao, Y., & Geverd, D. A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00471-0 · Cited by 49 · cited 1×
“…the Cell controversial since the progression of EMT, fibrosis, and MF accumulation is often accompanied by a reduction in Smad3 (or Smad2) levels (Zhao and Geverd, 2002; Poncelet et al., 2007; Meng et al., 2010), and suppression of Smad3 can actually facilitate SMA expression (Masszi et al.,…”
BackgroundShafer, S. L., & Towler, D. A. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.005 · Cited by 48 · cited 2×
“Synergy can also occur when a single cis element (e.g., SBE) is occupied by the Smad3–β-catenin complex, as was reported for the SM22α promoter (Shafer and Towler, 2009).”
BackgroundSmad3-mediated Myocardin Silencing
Xie, W.-B., Li, Z., Miano, J. M., Long, X., & Chen, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202747 · Cited by 47
The GSK-3/β-catenin-signalling axis in smooth muscle and its relationship with remodelling
Gosens, R., Meurs, H., & Schmidt, M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0269-8 · Cited by 35 · cited 4×
“, 2008), and hypertrophy (Deng et al., 2008; Gosens et al., 2008).”
BackgroundInfluentialHua, F., Zhou, J., Liu, J., Zhu, C., Cui, B., Lin, H., Liu, Y., Jin, W. L., Yang, H., & Hu, Z. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.042 · Cited by 31 · cited 2×
“Of importance, a recent publication reported that Smad3 and GSK-3β can directly associate (Hua et al., 2010).”
BackgroundE-cadherin regulates MAL-SRF-mediated transcription in epithelial cells
Busche, S., Kremmer, E., & Posern, G. (2010) · Journal of Cell Science · doi:10.1242/jcs.061887 · Cited by 25 · cited 1×
“In line with this, recent work (Busche et al., 2010) showed that uncoupling of E-cadherin is the key trigger for MRTF translocation upon calcium switch, whereas the changes in TJ integrity do not play a role.”
ResultZhang, M., Lee, C., Luo, D.-D., Krupa, A., Fraser, D. J., & Phillips, A. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700594200 · Cited by 14 · cited 3×
“On the other hand, β-catenin has been described as a binding partner of Smad3 (Tian and Phillips, 2002; Zhang et al., 2007, 2010).”
Background
Cited by
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge
Piersma, B., Bank, R. A., & Boersema, M. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00059 · Cited by 442
“Other reports contradict these findings and propose that β -catenin induces the expression of α SMA through interaction with myocardin-related transcription factor (MRTF), a process inhibited by Smad3 (52, 137).”
ResultInfluentialMechanisms of TGFβ-Induced Epithelial–Mesenchymal Transition
Moustakas, A., & Heldin, C.-H. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5070063 · Cited by 267
Van De Water, L., Varney, S., & Tomasek, J. J. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0393 · Cited by 251
“This inhibition by SMAD3 can be tempered by b-catenin.(146) Taken together, these findings support a model in which MRTF-A is central to establishing and maintaining the myofibroblast phenotype in response to mechanical tension (Figs.”
ResultThe Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Schuster, R., Younesi, F., Ezzo, M., & Hinz, B. (2023) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041231 · Cited by 232
Metadata
- Authors
- Charbonney, E., Speight, P., Masszi, A., Nakano, H., & Kapus, A.
- Affiliations
- St. Michael's Hospital (CA)
- Juntendo University (JP)
- Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Department of Surgery, University of Toronto, Toronto, ON M5B 1W8, Canada
- Venue
- Molecular Biology of the Cell
- Published
- 2011-12
- Volume
- 22
- Issue
- 23
- Pages
- 4472-4485
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC3226468
- OpenAlex
- W2129055432
- Cited by
- 84
- References
- 65
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 10 · 2013: 10 · 2012: 6
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Kidney Foundation of Canada
- Canadian Institutes of Health Research (MOP- 106625, 86535_1, TGF-53877)
- Japan Society for the Promotion of Science (23659404)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- β-catenin, Smad3, MRTF, adherens junctions, E-cadherin, TGF-β1, serum response factor, glycogen synthase kinase-3β, protein stability, ubiquitination, alpha-smooth muscle actin, organ fibrosis, CArG box
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Actins, Animals, Cells, Cultured, Epithelial Cells, Gene Expression Regulation, Promoter Regions, Genetic, Swine, Transcription Factors, Cadherins, Transforming Growth Factor beta, Adherens Junctions, Serum Response Factor, Glycogen Synthase Kinase 3, beta Catenin, Rats, Smad3 Protein, Protein Stability, Myofibroblasts, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.